Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1)

被引:361
|
作者
Aktas, H
Cai, H
Cooper, GM
机构
[1] DANA FARBER CANC INST,DIV MOL GENET,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
关键词
D O I
10.1128/MCB.17.7.3850
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of growth factor receptors by ligand binding initiates a cascade of events leading to cell growth and division. Progression through the fell cycle is controlled by cyclin-dependent protein kinases (Cdks), but the mechanisms that link growth factor signaling to the cell cycle machinery have not been established, We report here that Ras proteins play a key role in integrating mitogenic signals with cell cycle progression through G(I). Ras is required for cell cycle progression and activation of both Cdk2 and Cdk4 until similar to 2 h before the G(I)/S transition, corresponding to the restriction point, Analysis of Cdk-cyclin complexes indicates that Res signaling is required both for induction of cyclin D1 and for downregulation of the Cdk inhibitor p27(KIP1). Constitutive expression of cyclin D1 circumvents the requirement for Bas signaling in cell proliferation, indicating that regulation of cyclin D1 is a critical target of the Res signaling cascade.
引用
收藏
页码:3850 / 3857
页数:8
相关论文
共 50 条
  • [41] The cyclin kinase inhibitor (CKI) p27(Kip1) (p27) regulates the mesangial cell (MC) response to PDGF and bFGF, but not TGF-beta 1.
    Shankland, SJ
    Pippin, J
    Flanagan, M
    Coats, SR
    Nangaku, M
    Ferro, M
    Gordon, KL
    Roberts, JM
    Couser, WG
    Johnson, RJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2087 - A2087
  • [42] A recombinant adenovirus expressing p27(Kip1) induces cell cycle arrest and lass of cyclin-Cdk activity in human breast cancer cells
    Craig, C
    Wersto, R
    Kim, M
    Ohri, E
    Li, ZW
    Katayose, D
    Lee, SJ
    Trepel, J
    Cowan, K
    Seth, P
    ONCOGENE, 1997, 14 (19) : 2283 - 2289
  • [43] Role of the CDK Inhibitor p27 (Kip1) in Mammary Development and Carcinogenesis: Insights from Knockout Mice
    Elizabeth A. Musgrove
    Elizabeth A. Davison
    Christopher J. Ormandy
    Journal of Mammary Gland Biology and Neoplasia, 2004, 9 : 55 - 66
  • [44] Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: Insights from knockout mice
    Musgrove, EA
    Davison, EA
    Ormandy, CJ
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2004, 9 (01) : 55 - 66
  • [45] FKHRL1 inhibits the cell cycle progression of erythroid cells viaup-regulation of p27/Kip1
    Uchida, M
    Watanabe, T
    Kirito, K
    Iwama, A
    Osawa, M
    Ozawa, K
    Komatsu, N
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 43 - 43
  • [46] Cyclin-dependent kinase inhibitor p27(Kip1) expression in normal and neoplastic cervical epithelium
    Troncone, G
    Palombini, L
    deRosa, G
    diVizio, D
    Cukor, B
    Loda, M
    LABORATORY INVESTIGATION, 1997, 76 (01) : 645 - 645
  • [47] Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27(Kip1)
    CasacciaBonnefil, P
    Tikoo, R
    Kiyokawa, H
    Friedrich, V
    Chao, MV
    Koff, A
    GENES & DEVELOPMENT, 1997, 11 (18) : 2335 - 2346
  • [48] CONDITIONAL BINDING TO AND CELL-CYCLE-REGULATED INHIBITION OF CYCLIN-DEPENDENT KINASE COMPLEXES BY P27(KIP1)
    EBLEN, ST
    FAUTSCH, MP
    ANDERS, RA
    LEOF, EB
    CELL GROWTH & DIFFERENTIATION, 1995, 6 (08): : 915 - 925
  • [49] MOLECULAR ANALYSIS OF THE CYCLIN-DEPENDENT KINASE INHIBITOR GENE P27/KIP1 IN HUMAN MALIGNANCIES
    KAWAMATA, N
    MOROSETTI, R
    MILLER, CW
    PARK, D
    SPIRIN, KS
    NAKAMAKI, T
    TAKEUCHI, S
    HATTA, Y
    SIMPSON, J
    WILCZYNSKI, S
    LEE, YY
    BARTRAM, CR
    KOEFFLER, HP
    CANCER RESEARCH, 1995, 55 (11) : 2266 - 2269
  • [50] Upregulation of the cyclin-dependent kinase inhibitor p27(KIP1) in differentiating and postnatal RPE cells
    Defoe, DM
    Levine, EM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U578 - U578